spacer
home > ebr > autumn 2019 > trial by fire
PUBLICATIONS
European Biopharmaceutical Review

Trial by Fire




Cannabis policy change is sweeping across the globe. One by one, countries, states, and territories are turning back a century of cannabis prohibition, at times led by a chorus of voters, outraged patient groups, or sometimes championed by only a single mother.

Cannabis is not a therapeutic drug born in the usual way. It is not a molecule designed, conceived, or synthesised and then selected by chance from a library of designer candidate compounds. It was not discovered by accident by an observant scientist. Cannabis sativa is, in fact, not one thing at all, but the botanical factory of a chemical symphony that has evolved alongside humans for over millennia (1).

For a long time, we understood this and simply harnessed its abilities. Nicholas Culpeper wrote of hemp in his book from 1649, later known as The Complete Herbal, which read that it is "so well known… I shall not need to write any description of it” (2). Whether or not “…the juice dropped into the ears kills worms in them”, as he so colourfully describes, is, of course, subject to interpretation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Mark A Ware is currently the Chief Medical Officer at Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University, Canada, from July 2018 to work in this capacity. His research has been funded and supported by the Canadian Institutes of Health Research, FRQS, private foundations, and pharma companies. He has published over 100 papers on cannabis and pain research in academic journals, written six book chapters, and given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He served as a consultant to several large corporate and academic research programmes internationally and has advised the Canadian Federal Government on cannabis policy since 2001 and 2016, serving as the Vice Chair of the Federal Task Force on the legalisation and regulation of cannabis in Canada.
spacer
Dr Mark A Ware
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement